RIA
AUPH icon

Realta Investment Advisors’s Aurinia Pharmaceuticals AUPH Stock Holding History

Realta Investment Advisors’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-13,738
Closed -$68.8K – 782
2024
Q1 		$68.8K Sell
13,738
-1,353
-9% -$9.18K 0.01% 520
2023
Q4 		$136K Sell
15,091
-2,552
-14% -$21K 0.03% 422
2023
Q3 		$171K Hold
17,643
– – 0.04% 405
2023
Q2 		$171K Hold
17,643
– – 0.04% 422
2023
Q1 		$193K Hold
17,643
– – 0.05% 394
2022
Q4 		$76.2K Sell
17,643
-2,932
-14% -$17K 0.02% 519
2022
Q3 		$155K Sell
20,575
-688
-3% -$5.96K 0.04% 396
2022
Q2 		$242K Sell
21,263
-330
-2% -$3.69K 0.06% 308
2022
Q1 		$267K Buy
21,593
+4,472
+26% +$69.1K 0.05% 324
2021
Q4 		$392K Hold
17,121
– – 0.09% 259
2021
Q3 		$379K Hold
17,121
– – 0.09% 253
2021
Q2 		$222K Sell
17,121
-550
-3% -$7.01K 0.05% 356
2021
Q1 		$229K Buy
17,671
+5,944
+51% +$86.2K 0.06% 328
2020
Q4 		$162K Buy
11,727
+356
+3% +$5.18K 0.05% 318
2020
Q3 		$167K Buy
+11,371
New +$165K 0.06% 293
2020
Q1 		– Sell
-10,739
Closed -$86K – 372
2019
Q4 		$86K Hold
10,739
– – 0.02% 539
2019
Q3 		$57K Hold
10,739
– – 0.02% 638
2019
Q2 		$70K Hold
10,739
– – 0.02% 594
2019
Q1 		$70K Buy
+10,739
New +$71.2K 0.03% 466

Other funds holding AUPH

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Realta Investment Advisors's AUPH Position: Q2 2024 in Review

Realta Investment Advisors sold out of Aurinia Pharmaceuticals (AUPH) in Q2 2024, closing a stake of 13,738 shares — an estimated $68.8K sold.

Realta Investment Advisors first reported a position in AUPH in Q1 2019 and held it in 19 quarters. The position peaked at $392K in Q4 2021. 171 funds tracked by Wall St. Rank hold AUPH as of Q2 2024.

  • Realta Investment Advisors reported no remaining Aurinia Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Realta Investment Advisors sold 13,738 Aurinia Pharmaceuticals shares in Q2 2024, an estimated $68.8K.
  • Realta Investment Advisors first reported a position in Aurinia Pharmaceuticals in Q1 2019 and held it in 19 quarters.
  • Realta Investment Advisors's Aurinia Pharmaceuticals position peaked at $392K in Q4 2021.
  • 171 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2024.

Based on Realta Investment Advisors's 13F filing for Q2 2024, filed 15 Jul 2024.